top of page

Search

A Clinical Update in Gastroenteropancreatic Neuroendocrine Tumors and Carcinoid Syndrome ~ 9/14/21

Social Media Coordinator
Aug 25, 2021
1 min read

Please register at: https://ipsen.pharmagin.com/reg/IPSEN-Oncology-SLP150289

Host Mary Lyn Page 475-441-0908 mary.lyn.page@ipsen.com

Recent Posts

CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's

CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury

NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury

Comments

bottom of page